UTS site search
Centre for Health Economics Research and Evaluation
Project spotlight
CREST logo


CREST is the health economics national technical service established at CHERE and funded by Cancer Australia to develop resources to assist the Cancer Collaborative Clinical Trials Groups in the incorporation of health and pharmaco-economic analyses into trial protocols, as well as to build capacity for health economics.
Health Technology Assessment

Health Technology Assessment

The Economic Evaluation team at CHERE has expertise in undertaking economic evaluations of new health technologies and programs. It undertakes commissioned research for a range of agency, and also conducts rigorous evaluations of submissions and applications being considered by the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC).
Mike Woods, the former commissioner on the Productivity Commission’s 2011 inquiry into aged care, which led to the Living Longer Living Better reforms, has called on sector stakeholders to identify the key issues they want addressed in the review and to gather data as evidence to support their claims
CHERE is seeking an Associate Professor / Professor
Prof Marion Haas and Richard De Abreu Lourenco presented a workshop for the Translational Cancer Research Network (TCRN) titled "Economic Evaluations in Implementation Science"
A study by CHERE Research Fellow Richard De Abreu Lourenco seeks to understand what factors influence a woman’s choice about breast cancer treatment and managing the risk of recurrence